D. E. Shaw & Co., Inc.

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,113,738

+$16,551,317 QoQ

Shares Held

1,580,216

+3459.8% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#27

of 179 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ORIC ranks #56 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,113,738	1,580,216	+3459.8%	Shares	Defined	2026-08-14
2026-03-31	$562,421	44,390	+177.1%	Shares	Defined	2026-05-15
2025-12-31	$131,059	16,022	-83.7%	Shares	Defined	2026-02-17
2023-12-31	$905,583	98,433	-68.0%	Shares	Defined	2024-02-14
2023-09-30	$1,860,247	307,479	-32.2%	Shares	Defined	2023-11-14
2023-06-30	$3,517,212	453,249	-21.6%	Shares	Defined	2023-08-14
2023-03-31	$3,296,327	578,303	-4.1%	Shares	Defined	2023-05-15
2022-12-31	$3,550,415	602,787	+12.9%	Shares	Defined	2023-02-14
2022-09-30	$1,708,441	533,888	+5.5%	Shares	Defined	2022-11-14
2022-06-30	$2,266,821	505,987	+106.6%	Shares	Defined	2022-08-15
2022-03-31	$1,307,760	244,899	+2395.9%	Shares	Defined	2022-05-16
2021-03-31	$240,394	9,812	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.